Globus Medical (GMED) Free Cash Flow (2011 - 2026)

Globus Medical (GMED) has 16 years of Free Cash Flow data on file, last reported at $162.7 million in Q1 2026.

• For the quarter ending Q1 2026, Free Cash Flow rose 15.26% year-over-year to $162.7 million; the trailing twelve-month figure through Mar 2026 stood at $610.3 million (up 22.2% YoY), and the FY2025 full-year result was $588.8 million, up 45.3% from the prior year.
• Free Cash Flow for Q1 2026 stood at $162.7 million, up from $97.4 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $318.9 million in Q3 2025 and bottomed at -$17.8 million in Q3 2022.
• The 5-year median for Free Cash Flow is $47.0 million (2024), against an average of $87.8 million.
• The widest annual swing landed in 2022, when Free Cash Flow tumbled 122.98%; it then surged 35283.37% in 2024.
• A 5-year view of Free Cash Flow shows it stood at $112.3 million in 2022, then slipped by 27.14% to $81.8 million in 2023, then soared by 136.24% to $193.2 million in 2024, then tumbled by 49.61% to $97.4 million in 2025, then jumped by 67.16% to $162.7 million in 2026.
• The last three Free Cash Flow figures came in at $162.7 million (Q1 2026), $97.4 million (Q4 2025), and $318.9 million (Q3 2025), per Business Quant data.

Peer Comparison